Ayurcann Achieves Record-Breaking Sales Growth
Toronto, Ontario – Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0), a leading player in Canada’s cannabis industry, has reported remarkable financial and operational results for the fiscal year, with gross revenues reaching an astonishing $45,265,235. This year marks another milestone for Ayurcann, with a year-over-year growth of 100%, reflecting the company's continued expansion in the cannabis sector.
Flourishing Cannabis Market in Canada
The Canadian recreational cannabis market is thriving, with retail sales recording a staggering $4.4 billion for the year ending in July. This robust growth underscores the cannabis industry's upward trajectory since legalization, contributing to a vibrant commercial environment.
Ayurcann has capitalized on this momentum, establishing itself as one of the top performers and showcasing remarkable growth and resilience since its inception in 2020. Over the past three years, Ayurcann has consistently achieved 100% year-over-year growth, positioning itself as a formidable entity in this fast-evolving industry.
Broad National Presence and Market Penetration
With a presence that spans over 70% of retail cannabis stores nationwide, Ayurcann has developed a powerful distribution network, ensuring accessibility of its products from coast to coast. This expansive reach has been instrumental in the company's rapid revenue growth.
Ontario, as the largest cannabis market in Canada, serves as a significant focal point for Ayurcann's operations. The company has successfully penetrated over 83% of the market in this province, distributing its products across more than 1,300 retail outlets. Ayurcann's strong relationships with provincial boards and retailers have been pivotal in capturing substantial market share and fostering a dedicated customer base.
Highlights from the Fiscal Year Ended June 30, 2024
During the fiscal year, Ayurcann achieved several key milestones:
- Gross revenue soared to $45,265,235, doubling from $22,371,604 in the previous year.
- The company expanded its offerings to include 80 stock keeping units (SKUs) nationwide.
- Ayurcann reported an Adjusted EBITDA of $1,032,075, marking a significant improvement from the previous year's -$1,315,672.
- Ayurcann was recognized as the leading producer of vapes and ranked as a top five pre-roll manufacturer in Ontario.
CEO Igal Sudman expressed excitement about the cannabis industry’s maturation in Canada, highlighting the company’s successful navigation through increasing competition and retail price challenges. Ayurcann’s dedication to a business-to-consumer strategy has facilitated enhanced market share across various provinces.
Operational Highlights for the Year
As part of its operational growth, Ayurcann achieved:
- 30,500 product listings across numerous provinces, including Ontario and New Brunswick.
- Relentless innovation in product offerings to meet evolving consumer needs.
- A strong demand for Ayurcann’s variety of products and brands across Canada.
- Exploration of national and international brand opportunities.
- Development of strategic partnerships and robust industry relationships.
- Continuous investment in operational efficiency to spur future growth.
Igal Sudman further emphasized the company’s commitment to delivering value to its stakeholders and continuing its innovative approach to product development.
About Ayurcann Holdings Corp.
Ayurcann is renowned as a leading post-harvest solution provider dedicated to creating high-quality, tailored products for the adult-use and medical cannabis sectors in Canada. The company aims to be the partner of choice for premier Canadian cannabis brands, offering services such as ethanol extraction, formulation, and custom manufacturing solutions.
For more information, please contact:
Igal Sudman, Chairman and Chief Executive Officer
Ayurcann Holdings Corp.
Tel: 905-492-3322
Email: info@ayurcann.com
Frequently Asked Questions
What is Ayurcann's revenue for the fiscal year 2024?
Ayurcann reported a gross revenue of $45,265,235 for the fiscal year ended June 30, 2024, reflecting a 100% increase from the previous year.
How has Ayurcann established itself in the cannabis market?
Ayurcann has established itself as a top performer by rapidly scaling its operations and achieving consistent year-over-year growth.
What are the key products offered by Ayurcann?
The company offers a diverse range of products including vapes, concentrates, and flower categories, with a total of 80 SKUs available.
How does Ayurcann's market presence look across Canada?
Ayurcann's products are available in over 70% of cannabis retail stores across Canada, showcasing its broad national presence.
What are Ayurcann's future plans?
Ayurcann plans to continue its expansion by exploring national and international opportunities while focusing on innovation and strengthening industry relationships.
